Related Image: Video shows nanotube spins as it grows |
(Date:12/2/2009)...LYSTAD, The Netherlands, December 2 /PRNewswire/ -...hnology company focusing on protein mimicking,tech...oday announced that it,has appointed Wim E.M. Mol,...Dr. Mol will be responsible for all of Pepscans co...trategic direction of the company. He brings to,Pe...
(Date:12/2/2009)...NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcer...) (NYSE: SCR ), a leading pharmaceutical company...nd marketing of branded,generic and proprietary ph...f,its drugs have been included in China,s National...d by China,s Ministry of Human Resources and Socia...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has joi...is redesigned website at www.DrKerrySolomon.com ,... Dr. Solomon is a proven LASIK, lens implant, and ...y recognized for his substantial contributions to ...er of Trusted LASIK Surgeons, which screens LASIK ...
(Date:12/1/2009)...H, Mass., Dec. 1 Harvest Technolog...results from the company sponsored 60-patient clin...nter in Chennai, India using the company,s BMAC Sy...itical Limb Ischemia (CLI). Sri Ramachandra Medica...ated institution based in Chennai, India and one o...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3...e Wisconsin Technology Council is taking applicati... , in which entrepreneurs quite likely hundreds o...t. , ,The last two years, grand-prize winners have...so chosen in advanced manufacturing, business serv...005 finalists are still in business and more than ...
...adison, Wis. Sonic Foundry premiered this week...y believe is an untapped audience on the Internet ...xpert knowledge. , ,The site features direct links...dia software and server tools, which combine audio...hows and text. The site debuted with almost 7,000 ...
...sconsin,s first statewide online high-school progr...blems that led to a massive shortfall on initial e...rts. , ,IQ Academies was supposed to generate $1 m...s operated by the 2006-07 school year, but is now ...-2006. , ,Officials said fewer students signed up ...
Other Biology Technology:Sonic Foundry creates search engine for 7,000 expert video presentations 2(Date:12/2/2009)...untain forest,s woodland herb population has shown...tories recover from logging, according to Purdue U...ortions of the forest nearly 80 years ago, the dis...st floor was similar to that of undisturbed areas....forestry and natural resources, said that contrast...
(Date:12/2/2009)...orgia College of Veterinary Medicine have made an ...enues for treating Ichthyophthirius multifiliis, o...asite that commonly attacks freshwater fish. , W...s found that Ich harbors two apparently symbiotic ...ually found free-living, and Rickettsia, which are...
(Date:12/2/2009)...enter researchers have figured out how stem cells ... able to resist radiation therapy. And using a dru... cancer stem cells, they were able to kill many mo...eriment. , The work builds off earlier research...fects of radiation much better than other cancer c...
Breaking Biology News(10 mins):Study finds logging effects vary based on a forest's history, climate 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Discovery makes brain tumor cells more responsive to radiation 2Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 1Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 2Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 4Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13924 1Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13924 2VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 1VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 2VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 3VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 4VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 5VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 6VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 7VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 8VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 9...e reagents required for a fast and convenient dete... in cell and tissue extracts and in purified micro...sted on samples prepared from mammalian tissues su...le from several species, as well as on lysates fro...
...vides the reagents to efficiently differentiate mo... By efficiently promoting myogenic differentiation...myogenesis, transcription factor regulation, and i...t therapy. By providing the means to obtain and ma...
...on Assay is an anchorage-independent growth assay ...nt assay for detecting malignant transformation of...arcinogens or carcinogen inhibitors) are cultured ...21-28 days. Following this incubation period, for...
Varian 2200 Ion Trap GC/MS from Varian, Inc.
Biology Products: